Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
38.00
+1.55 (4.25%)
Oct 22, 2024, 4:00 PM EDT - Market closed
Tarsus Pharmaceuticals Market Cap
Tarsus Pharmaceuticals has a market cap or net worth of $1.45 billion as of October 23, 2024. Its market cap has increased by 171.73% in one year.
Market Cap
1.45B
Enterprise Value
1.20B
1-Year Change
171.73%
Ranking
Category
Stock Price
$38.00
Market Cap Chart
Since the IPO on October 16, 2020, Tarsus Pharmaceuticals's market cap has increased from $308.14M to $1.45B, an increase of 369.13%. That is a compound annual growth rate of 46.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2024 | 1.45B | 115.63% |
| Dec 29, 2023 | 670.40M | 71.46% |
| Dec 30, 2022 | 391.00M | -15.95% |
| Dec 31, 2021 | 465.20M | -44.61% |
| Dec 31, 2020 | 839.80M | 172.53% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| STAAR Surgical Company | 1.50B |
| Integra LifeSciences Holdings | 1.49B |
| Tyra Biosciences | 1.49B |
| Xencor | 1.48B |
| Progyny | 1.46B |
| Day One Biopharmaceuticals | 1.44B |
| Dynavax Technologies | 1.44B |
| AdaptHealth | 1.43B |